BioCentury
ARTICLE | Product Development

Ears wide open

How hearing loss became an investable space

June 2, 2017 7:41 PM UTC

Based on unmet need alone, hearing loss should have been every bit as attractive to investors and drug developers as ophthalmic diseases, which entered a renaissance in the mid-2000s resulting in a multibillion-dollar market for innovative drugs today.

Both markets have been growing as populations in developed countries age, and both had long been starved of pharmaceutical innovation...